KR970703137A - 배뇨장해 치료용 경피투여제제(percutaneously administrable preparation for treating urination disorder) - Google Patents
배뇨장해 치료용 경피투여제제(percutaneously administrable preparation for treating urination disorder) Download PDFInfo
- Publication number
- KR970703137A KR970703137A KR1019960706510A KR19960706510A KR970703137A KR 970703137 A KR970703137 A KR 970703137A KR 1019960706510 A KR1019960706510 A KR 1019960706510A KR 19960706510 A KR19960706510 A KR 19960706510A KR 970703137 A KR970703137 A KR 970703137A
- Authority
- KR
- South Korea
- Prior art keywords
- molecular weight
- drug
- transdermal
- urination
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
배뇨장해치료약을 저분자량 폴리이소부틸렌, 고분자량 폴리이소부틸렌 및 유지를 주기제로 함유하는 점착제 중에 함유시켜서 구성되는 배뇨장해치료용 경피투여제제이다. 또, 배뇨장해 치료약은 저분자량 폴리이소부틸렌, 고분자량 폴리이소부틸렌, 유지 및 스티렌이소프렌스티렌블록 공중합체를 주기제로 함유하는 점착제중에 함유시켜서 구성되는 배뇨장해치료용 경피투여제제이다. 본 발명의 배뇨장해치료용 경피투여제제는 이와 같은 특정 기제성분을 사용함으로써 경시적 안정성이 우수하고, 피부에 대해여 저자극성이고, 게다가 경피흡수성에도 우수하다.
Description
배뇨장해 치료용 경피투여제제(PERCUTANEOUSLY ADMINISTRABLBLE PREPARATION FOR TREATING URINATION DISORDER)
[도면의 간단한 설명]
제1도는 래트에 의한 경피흡수시험결과를 도시한다,
제2도는 사람 피부에 의한 경피흡수시험결과를 도시한다,
제1도 및 제2도에 있어서, ○은 하기의 실시예 1의 제제, ●은 하기 실시예 2의 제제, □은 하기 실시예 3의 제제, ■은 하기 실시예 4의 제제, ◇은 하기 실시예 5의 제제, ×는 하기 실시예 6의 제제,은 하기 실시예 7의 제제, ◆은 하기 비교예 1의 제제, △은 하기 비교예 2의 제제, □은 하기 비교예 3의 제제, |은 하기 비교예 4의 제제,은 하기 비교예 19의 제제,비교예 20의 제제의 결과를 나타낸다.
제3도는 래트에 의한 시스토메트리법에 의한 약효 평가시험 결과를 도시한다.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 배뇨장해 치료약을 저분자량 폴리이소부틸렌, 고분자량 폴리이소부틸렌 및 유지를 주기제로서 함유하는 점착제중에 함유시켜서 구성되는 배뇨장해 치료용 경피투여제제.
- 제1항에 있어서, 상기 점착제의 전체중량에 의거하여, 상기 배뇨장해치료약 0.01∼50중량부를 상기 저분자량 폴리이소부틸렌 1∼60중량부, 상기 고분자량 폴리이소부틸렌 0.1∼40중량부 및 상기 유지 10∼60중량부를 주기제로서 함유하는 점착제중에 함유시켜서 구성되는 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 배뇨장해치료약을 저분자량 폴리이소부틸렌, 고분자량 폴리이소부틸렌, 유지 및 스티렌이소프렌스티렌블록 공중합체를 주기제로 함유하는 점착제중에 함유시켜서 구성되는 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 제3항에 있어서, 상기 점착제의 전체중량에 의거하여, 상기 배뇨장해치료약 0.01∼50중량부를 상기 저분자량 폴리이소부틸렌 1∼60중량부, 상기 고분자량 폴리이소부틸렌 0.1∼40중량부, 상기 유지 10∼60중량부 및 상기 스티렌이소프렌스티렌블록 공중합체 5∼50중량부를 주기제로 함유하는 점착제중에 함유시켜서 구성되는 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 배뇨장해치료약이 요실금치료약, 배뇨곤란치료약, 빈뇨치료약 또는 배뇨통 치료약인 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 배뇨장해치료약이 요실금치료약인 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 저분자량 폴리이소부틸렌의 점도평균 분자량이 10,000∼100,000이고, 상기 고분자량 폴리이소부틸렌의 점도평균 분자량이 500,000∼2,500,000인 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 유지가 점도 5∼100mm2/S의 유동 파라핀, 천연 및 합성 스쿠알렌 및 스쿠알란으로 이루어지는 군에서 선택된 적어도 1종인 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.
- 제l항 내지 제8항 중 어느 한 항에 있어서, 경피흡수촉진제를 더 포함하는 것을 특징으로 하는 배뇨장해 치료용 경피투여제제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP94-128162 | 1994-05-18 | ||
JP12816294 | 1994-05-18 | ||
PCT/JP1995/000946 WO1995031190A1 (fr) | 1994-05-18 | 1995-05-18 | Preparation administrable par voie percutanee pour le traitement des troubles de la miction |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970703137A true KR970703137A (ko) | 1997-07-03 |
Family
ID=14977927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960706510A KR970703137A (ko) | 1994-05-18 | 1995-05-18 | 배뇨장해 치료용 경피투여제제(percutaneously administrable preparation for treating urination disorder) |
Country Status (8)
Country | Link |
---|---|
US (1) | US5770221A (ko) |
EP (1) | EP0760238B1 (ko) |
KR (1) | KR970703137A (ko) |
AU (1) | AU2454495A (ko) |
DE (1) | DE69526437T2 (ko) |
DK (1) | DK0760238T3 (ko) |
ES (1) | ES2172584T3 (ko) |
WO (1) | WO1995031190A1 (ko) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
US5843472A (en) * | 1997-02-28 | 1998-12-01 | Cygnus, Inc. | Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use |
US5879701A (en) * | 1997-02-28 | 1999-03-09 | Cygnus, Inc. | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
JP4073517B2 (ja) * | 1997-04-07 | 2008-04-09 | 久光製薬株式会社 | 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤 |
PT1094781E (pt) * | 1998-07-07 | 2008-10-08 | Transdermal Technologies Inc | Composições para administração transdérmica rápida e não irritante de agentes farmacologicamente activos e métodos para formulação de tais composições e sua administração |
AU2940000A (en) * | 1999-03-11 | 2000-09-28 | Mitsubishi Chemical Corporation | Drug composition for percutaneous absorption |
AU3536799A (en) * | 1999-04-26 | 2000-11-10 | Lead Chemical Co., Ltd. | Percutaneous preparations containing oxybutynin |
CN1192769C (zh) * | 1999-08-09 | 2005-03-16 | 山之内制药株式会社 | 下部尿路症治疗用医药组合物 |
WO2001021167A1 (en) * | 1999-09-22 | 2001-03-29 | Merck & Co., Inc. | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
ATE353636T1 (de) * | 1999-12-15 | 2007-03-15 | Hisamitsu Pharmaceutical Co | Adhäsive zubereitungen |
JP4854163B2 (ja) * | 2000-04-18 | 2012-01-18 | 久光製薬株式会社 | 抗炎症剤含有貼付剤 |
JP2001328935A (ja) * | 2000-05-19 | 2001-11-27 | Hisamitsu Pharmaceut Co Inc | 貼付剤 |
US20020198215A1 (en) * | 2000-10-23 | 2002-12-26 | Lino Tavares | Terazosin transdermal device and methods |
EP1437130A4 (en) * | 2001-10-17 | 2009-08-26 | Hisamitsu Pharmaceutical Co | PERCUTANEOUS ABSORPTION PREPARATIONS |
JP4354678B2 (ja) * | 2002-08-28 | 2009-10-28 | 久光製薬株式会社 | 貼付剤 |
TWI296531B (en) | 2002-10-18 | 2008-05-11 | Hisamitsu Pharmaceutical Co | Transdermal adhesive preparations for topical administration of fentanyl |
US20060188554A1 (en) * | 2003-08-04 | 2006-08-24 | Katashi Nakashima | Transdermal absorption preparation |
EP1676895B1 (en) * | 2003-10-20 | 2013-05-08 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch for external use on skin |
DE10357321A1 (de) * | 2003-12-05 | 2005-07-21 | Tesa Ag | Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung |
DE102004009903A1 (de) * | 2004-02-26 | 2005-09-22 | Grünenthal GmbH | Pflaster mit reduzierter Hautirritation |
JP5208348B2 (ja) * | 2004-05-13 | 2013-06-12 | 旭化成ファーマ株式会社 | ナフトピジルを含有する医薬 |
KR101312814B1 (ko) * | 2005-02-03 | 2013-09-27 | 오노 야꾸힝 고교 가부시키가이샤 | 경피 흡수형 제제 |
JPWO2006118173A1 (ja) * | 2005-04-28 | 2008-12-18 | 小野薬品工業株式会社 | 経皮吸収製剤 |
JP4921739B2 (ja) * | 2005-08-10 | 2012-04-25 | 久光製薬株式会社 | 皮膚刺激を低減した貼付剤 |
WO2007021008A1 (ja) * | 2005-08-19 | 2007-02-22 | Dia Pharmaceutical Co., Ltd. | プラスターの製造方法及びその製造装置及びプラスタ-用ライナ- |
JP4784875B2 (ja) | 2006-04-11 | 2011-10-05 | ニチバン株式会社 | タムスロシン含有経皮吸収型製剤 |
US20100092544A1 (en) * | 2008-10-14 | 2010-04-15 | Katsuhiro Okada | Adhesive composition for patch and use thereof |
JPWO2013081014A1 (ja) * | 2011-11-28 | 2015-04-27 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
WO2016088898A1 (ja) * | 2014-12-05 | 2016-06-09 | 株式会社 ケイ・エム トランスダーム | 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤 |
US11186564B2 (en) * | 2016-08-04 | 2021-11-30 | Sunovion Pharmaceuticals Inc. | Dual NAV1.2/5HT2a inhibitors for treating CNS disorders |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4262003A (en) * | 1975-12-08 | 1981-04-14 | Alza Corporation | Method and therapeutic system for administering scopolamine transdermally |
DE3344691A1 (de) * | 1983-12-10 | 1985-06-20 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgasesysteme |
JPS6145052A (ja) * | 1984-08-07 | 1986-03-04 | 有限会社 ▲カゲ▼山商事 | 桟瓦 |
EP0204968B1 (de) * | 1985-05-24 | 1989-09-27 | Beiersdorf Aktiengesellschaft | Nitro-Pflaster |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US4793337A (en) * | 1986-11-17 | 1988-12-27 | E. R. Squibb & Sons, Inc. | Adhesive structure and products including same |
US5059189A (en) * | 1987-09-08 | 1991-10-22 | E. R. Squibb & Sons, Inc. | Method of preparing adhesive dressings containing a pharmaceutically active ingredient |
JPH0725669B2 (ja) * | 1988-12-23 | 1995-03-22 | 日東電工株式会社 | 経皮投与用医薬製剤 |
US5508038A (en) * | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
JP2869167B2 (ja) * | 1990-08-09 | 1999-03-10 | 日東電工株式会社 | 徐放性貼付製剤 |
JP3136413B2 (ja) * | 1991-02-22 | 2001-02-19 | リードケミカル株式会社 | 経皮吸収型頻尿・尿失禁治療剤 |
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
ZA933349B (en) * | 1992-05-13 | 1994-06-15 | Alza Corp | Transdermal administration of oxybutynin |
US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
US5503843A (en) * | 1994-04-22 | 1996-04-02 | Flora Inc. | Transdermal delivery of alpha adrenoceptor blocking agents |
-
1995
- 1995-05-18 US US08/737,160 patent/US5770221A/en not_active Expired - Lifetime
- 1995-05-18 WO PCT/JP1995/000946 patent/WO1995031190A1/ja active IP Right Grant
- 1995-05-18 DK DK95918735T patent/DK0760238T3/da active
- 1995-05-18 KR KR1019960706510A patent/KR970703137A/ko not_active Application Discontinuation
- 1995-05-18 EP EP95918735A patent/EP0760238B1/en not_active Expired - Lifetime
- 1995-05-18 AU AU24544/95A patent/AU2454495A/en not_active Abandoned
- 1995-05-18 DE DE69526437T patent/DE69526437T2/de not_active Expired - Lifetime
- 1995-05-18 ES ES95918735T patent/ES2172584T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1995031190A1 (fr) | 1995-11-23 |
DE69526437T2 (de) | 2002-10-31 |
EP0760238B1 (en) | 2002-04-17 |
DK0760238T3 (da) | 2002-07-22 |
DE69526437D1 (de) | 2002-05-23 |
AU2454495A (en) | 1995-12-05 |
US5770221A (en) | 1998-06-23 |
ES2172584T3 (es) | 2002-10-01 |
EP0760238A1 (en) | 1997-03-05 |
EP0760238A4 (en) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970703137A (ko) | 배뇨장해 치료용 경피투여제제(percutaneously administrable preparation for treating urination disorder) | |
Katz | Management of spasticity | |
CA1320442C (en) | Impotence ointment | |
Kirshblum | Treatment alternatives for spinal cord injury related spasticity | |
AU744980B2 (en) | Skin preparation | |
KR0143916B1 (ko) | 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법 | |
Suputtitada et al. | The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity | |
US5612382A (en) | Composition for percutaneous absorption of pharmaceutically active ingredients | |
Botte et al. | Treatment of acquired muscle spasticity using phenol peripheral nerve blocks | |
IE62587B1 (en) | Composition for the treatment of erectile dysfunction | |
BR9812134A (pt) | Composição farmacêutica para tratamento de dismenorréia e parto prematuro | |
WO2006017632A1 (en) | An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain | |
Esquenazi et al. | Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning | |
JPS63132825A (ja) | 血管拡張剤のゲル化軟膏 | |
BR9912508A (pt) | Métodos e composições transdérmicas para alìvio da dor | |
KR920703041A (ko) | 통증을 수반하는 염증성 또는 알레르기성 질환치료에 사용되는 성분물과 그 방법 | |
KR950028767A (ko) | 피부통과 투약을 위한 신규의 약제학적 투여 형태 | |
WO1999038472A2 (en) | Topical vasodilatory gel composition and methods of use and production | |
AU7069000A (en) | Apparatus and method for anesthetizing the cervical region of a female | |
Clarke | Effectiveness of rehabilitation in arthritis | |
Young et al. | Current issues in spasticity management | |
ES2074402A1 (es) | Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones. | |
Dietz et al. | The syndrome of spastic paresis | |
Pannikar et al. | Effect of epicondylectomy in early ulnar neuritis treated with steroids | |
JPH083069A (ja) | 経皮吸収促進剤及び皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |